164 related articles for article (PubMed ID: 7486159)
21. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog.
Zornow MH; Fleischer JE; Scheller MS; Nakakimura K; Drummond JC
Anesth Analg; 1990 Jun; 70(6):624-30. PubMed ID: 1971500
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of water permeability in the rat collecting duct: effect of imidazoline and alpha-2 compounds.
Kudo LH; Hébert CA; Rouch AJ
Proc Soc Exp Biol Med; 1999 Jun; 221(2):136-46. PubMed ID: 10352125
[TBL] [Abstract][Full Text] [Related]
23. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
24. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
Gargalidis-Moudanos C; Parini A
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
[TBL] [Abstract][Full Text] [Related]
25. Agmatine inhibits arginine vasopressin-stimulated urea transport in the rat inner medullary collecting duct.
Rouch AJ; Kudo LH
Kidney Int; 2002 Dec; 62(6):2101-8. PubMed ID: 12427134
[TBL] [Abstract][Full Text] [Related]
26. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
Sannajust F; Head GA
Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
[TBL] [Abstract][Full Text] [Related]
27. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
28. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
Weinger MB; Segal IS; Maze M
Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
[TBL] [Abstract][Full Text] [Related]
29. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference.
Burke J; Kharlamb A; Shan T; Runde E; Padillo E; Manlapaz C; Wheeler L
Ann N Y Acad Sci; 1995 Jul; 763():78-95. PubMed ID: 7677389
[TBL] [Abstract][Full Text] [Related]
30. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane.
Potter DE; Ogidigben MJ
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2799-805. PubMed ID: 1680113
[TBL] [Abstract][Full Text] [Related]
31. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine.
Zornow MH
Neuropharmacology; 1991 Oct; 30(10):1065-71. PubMed ID: 1684646
[TBL] [Abstract][Full Text] [Related]
32. RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.
Brown CM; MacKinnon AC; Redfern WS; Williams A; Linton C; Stewart M; Clague RU; Clark R; Spedding M
Br J Pharmacol; 1995 Sep; 116(2):1737-44. PubMed ID: 8528553
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
Mest HJ; Thomsen P; Raap A
Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
[TBL] [Abstract][Full Text] [Related]
34. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
[TBL] [Abstract][Full Text] [Related]
35. Oral dexmedetomidine preserves baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs.
Devcic A; Schmeling WT; Kampine JP; Warltier DC
Anesthesiology; 1994 Aug; 81(2):419-30. PubMed ID: 8053593
[TBL] [Abstract][Full Text] [Related]
36. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
Regunathan S; Youngson C; Raasch W; Wang H; Reis DJ
J Pharmacol Exp Ther; 1996 Mar; 276(3):1272-82. PubMed ID: 8786560
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze V; Chen BX; Li Z; Maze M
Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
[TBL] [Abstract][Full Text] [Related]
38. Thoracic epidural anesthesia attenuates halothane-induced myocardial sensitization to dysrhythmogenic effect of epinephrine in dogs.
Kamibayashi T; Hayashi Y; Mammoto T; Yamatodani A; Taenaka N; Yoshiya I
Anesthesiology; 1995 Jan; 82(1):129-34. PubMed ID: 7832294
[TBL] [Abstract][Full Text] [Related]
39. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
Yokota S; Hikasa Y; Mizushima H
Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
[TBL] [Abstract][Full Text] [Related]
40. The imidazoline-guanidinium receptor site, a target for some alpha-2 adrenergic agonists, is involved in inhibition of Na(+)-H+ exchange in renal proximal tubule cells.
Bidet M; Poujeol P; Parini A
J Hypertens Suppl; 1991 Dec; 9(6):S216-7. PubMed ID: 1687868
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
